Autoimmune central nervous system paraneoplastic disorders: mechanisms, diagnosis, and therapeutic options (Q41270524)

29 September 2017

1 reference

title

Autoimmune central nervous system paraneoplastic disorders: mechanisms, diagnosis, and therapeutic options (English)

1 reference

29 September 2017

Dropcho EJ

1

1 reference

29 September 2017

publication date

1 May 1995

1 reference

29 September 2017

1 reference

29 September 2017

volume

37 Suppl 1

1 reference

29 September 2017

page(s)

S102-13

1 reference

Paraneoplastic cerebellar degeneration. II. Clinical and immunologic findings in 21 patients with Hodgkin's disease

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

Carcinomatous cerebellar degeneration, encephalomyelitis, and sensory neuropathy (radiculitis). Report of a case incorporating both purely degenerative and intense inflammatory changes, with special prominence of the latter in the putamen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

Subacute cerebellar degeneration and Eaton-Lambert syndrome with bronchogenic carcinoma. A case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

Coexistence of Lambert-Eaton myasthenic syndrome and subacute cerebellar degeneration: differential effects of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

Gynecologic cancer in patients with subacute cerebellar degeneration predicted by anti-Purkinje cell antibodies and limited in metastatic volume.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

Temporal lobectomy for partial complex seizures: evaluation, results, and 1-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

Paraneoplastic cerebellar disease. Remission with excision of the primary tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

Partial characterization of the Purkinje cell antigens in paraneoplastic cerebellar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

Anticerebellar antibodies in neurologically normal patients with ovarian neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

Paraneoplastic cerebellar degeneration: a clinical comparison of patients with and without Purkinje cell cytoplasmic antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

A variant of the anti-Purkinje cell antibody in a patient with paraneoplastic cerebellar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

Steroid-induced weakness in patients with primary brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

Immunohistochemical analysis of the immune reaction in the nervous system in paraneoplastic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

Analysis of the IgG subclass distribution and inflammatory infiltrates in patients with anti-Hu-associated paraneoplastic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

Neuronal antinuclear antibody in sensory neuronopathy from lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

Localization of antibody in the central nervous system of a patient with paraneoplastic encephalomyeloneuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

Seronegativity for type 1 antineuronal nuclear antibodies ('anti-Hu') in subacute sensory neuronopathy patients without cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

Hel-N1: an autoimmune RNA-binding protein with specificity for 3' uridylate-rich untranslated regions of growth factor mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

Paraneoplastic Anti-Neuronal Nuclear IgG Autoantibodies (Type I) Localize Antigen in Small Cell Lung Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

Occult neuroblastoma presenting with opsomyoclonus: utility of computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

Paraneoplastic opsoclonus-myoclonus. Association with medullary thyroid carcinoma and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

Opsoclonus in adults. Report of three cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

Opsoclonus and parenchymatous degeneration of the cerebellum: The cerebellar origin of an abnormal ocular movement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

Opsoclonus, Occult Carcinoma, and Chemical Pathology in Dentate Nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

Neuropathologic Findings in a Patient With Neuroblastoma and Myoclonic Encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

Paralysis of fourth cranial nerve due to superior cerebellar artery aneurysm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

Characterization and primary structure of the poly(C)-binding heterogeneous nuclear ribonucleoprotein complex K protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

Intraneuronal accumulation of myeloma proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

Anti-Purkinje cell antibody producing B-cell lines from a patient with paraneoplastic cerebellar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

Effect of plasmapheresis on serum and CSF autoantibody levels in CNS paraneoplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

Opsoclonus: Its clinical value

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

Ocular involvement in neuroblastoma: prognostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370711

21 January 2018

Identifiers

DOI

10.1002/ANA.410370711

1 reference

29 September 2017

1 reference